We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
News & ViewsFree Access

Conference Scene: A bright future for tissue engineering and regenerative medicine in the Asia Pacific region

    Jessica E Frith*

    Tissue Engineering & Microfluidics Laboratory, Australian Institute for Bioengineering & Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia

    *Authors contributed equally

    Search for more papers by this author

    ,
    James E Hudson*

    Tissue Engineering & Microfluidics Laboratory, Australian Institute for Bioengineering & Nanotechnology, University of Queensland, St Lucia, QLD 4072, Australia

    *Authors contributed equally

    Search for more papers by this author

    &
    Justin J Cooper-White

    † Author for correspondence

    School of Chemical Engineering, University of Queensland, St Lucia, QLD 4072, Australia.

    Published Online:https://doi.org/10.2217/rme.11.7

    The Tissue Engineering and Regenerative Medicine International Society – Asia Pacific (TERMIS-AP) annual meeting was held in Sydney, Australia from 15–17 September 2010 and highlighted the latest developments in tissue engineering and regenerative medicine in the Asia–Pacific region. Several of the plenary lectures focused on the vascularization of tissue engineering constructs, an issue that is critical for the success of larger tissue engineered constructs and was central to the meeting overall. In addition, a wide range of research also presented developments in tissue engineering for a range of body tissues (including cardiac, neural, bone, cartilage, tendon, skeletal muscle and skin), as well as advances in technologies (high-throughput screening and microfluidics). Looking more broadly, the meeting incorporated developments covering the spectrum of fundamental research through to clinical studies, with discussions on how best to direct the scientific advances being made into realistic therapies that could be made widely available in the future. Overall, the meeting highlighted the promise of early strategies, which are now showing promising results in clinical trials, and the development of a strong foundation of research from which future therapies will no doubt be developed.

    References

    • Langer R, Vacanti J: Tissue engineering. Science260(5110),920–926 (1993).
    • Place ES, Evans ND, Stevens MM: Complexity in biomaterials for tissue engineering. Nat. Mater.8(6),457–470 (2009).
    • Gronthos S, Zannettino ACW, Hay SJ et al.: Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J. Cell Sci.116(9),1827–1835 (2003).
    • 101  US Department of Health and Human Services: Health, United States, 2009 with a special feature on medical technology www.cdc.gov/nchs/hus/special.htm